Oxis Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbuhaler, is a long‑acting β‑2 agonist presented as a dry‑powder inhalation formulation for inhalation use. It provides bronchodilation for patients with chronic obstructive pulmonary disease and asthma. GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Formoterol fumarate dihydrate is a bronchodilator that acts on the airway smooth muscle to improve airflow in obstructive lung diseases.

- Asthma: improves control of symptoms and reduces the need for rescue medication. - Chronic obstructive pulmonary disease (COPD): enhances lung function and decreases exacerbation frequency. - Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

Formoterol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Tremor: mild shaking of the hands. - Headache: transient headache. - Throat irritation: mild discomfort in the throat. - Cough: occasional dry cough. - Palpitations: sensation of a rapid or irregular heartbeat. - Nasal congestion: feeling of a blocked nose.

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing. - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Hypokalemia: low blood potassium levels. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing.

When using Oxis Turbuhaler, patients and healthcare providers should consider several safety measures.

- Assess respiratory status: evaluate the severity of asthma or COPD before initiating therapy. - Review medical history: identify any cardiovascular conditions or thyroid disorders that could be affected. - Monitor for adverse effects: watch for signs of paradox or bronchospasm or cardiac issues. - Avoid concomitant use with non‑ discrimin non‑ the    - Use the ​   - Store at below 25°C: keep the inhaler in its original pack and protect from moist 

The       """"   ... 

t   t  \